Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (733)	9/2/2005 10:11:46 AM
From: quidditch	Read Replies (1) of 946

Ice, yes those are the prescribed disclosures under Reg. S-K, if there are no disagreements in the resignation/firing of an independent accountant. My only point is that if it were as simple as a cost issue, CTIC would have had a successor lined up when GT resigned. It is clear that GT no longer wanted CTIC as a client, and the question is why. Accounting firms have ways of signaling when they want to dismiss the client, and the process usually then becomes collaborative. In this case, for whatever the reason, it was not. quid

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next